ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurology

Top Neurology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MIGUEL GUTIERREZ M.D.

Neurology

22,365

$2.87M

1861
1343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$129
Average prescription price

Avg: $218

DARIO NARRO M.D.

Neurology

11,337

$1.59M

1059
837 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 28%

$141
Average prescription price

Avg: $218

DANNY BARTEL M.D.

Neurology

11,216

$1.69M

953
453 are 65+

12%
patients receiving schedule two controlled substances

Avg: 2%

44%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 28%

$151
Average prescription price

Avg: $218

RICHARD HAMER MD

Neurology

10,787

$1.92M

962
682 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$178
Average prescription price

Avg: $218

DANIEL HYUN MD

Neurology

9,294

$1.42M

1159
786 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 28%

$152
Average prescription price

Avg: $218

EASWAR SUNDARAM MD

Neurology

7,914

$1.25M

678
386 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$158
Average prescription price

Avg: $218

LUIS GAITAN M.D.

Neurology

7,813

$1.19M

1244
965 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 28%

$152
Average prescription price

Avg: $218

JOSE MATUS MD

Neurology

7,065

$1.14M

549
260 are 65+

20%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$161
Average prescription price

Avg: $218

GODOFREDO ROSSI M.D.

Neurology

6,830

$741K

730
568 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$109
Average prescription price

Avg: $218

LEE POLLACK MD

Neurology

6,570

$903K

280
133 are 65+

36%
patients receiving schedule two controlled substances

Avg: 2%

44%
patients receiving schedule three controlled substances

Avg: 5%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$137
Average prescription price

Avg: $218

GEORGE PLOTKIN MD

Neurology

6,232

$1.3M

534
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 28%

$209
Average prescription price

Avg: $218

ZUKA KHABBAZEH M.D.

Neurology

5,960

$1.56M

542
385 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 28%

$261
Average prescription price

Avg: $218

EVERTON EDMONDSON M.D.

Neurology

5,920

$724K

321
142 are 65+

57%
patients receiving schedule two controlled substances

Avg: 2%

43%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$122
Average prescription price

Avg: $218

DOUGLAS LEWIS D.O.

Neurology

5,898

$1.34M

407
253 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 28%

$228
Average prescription price

Avg: $218

MOHAMMED ATHARI M.D.

Neurology

5,483

$490K

399
223 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

29%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $218

SIVARAM SUDHAKAR M.D.

Neurology

5,353

$780K

613
402 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$146
Average prescription price

Avg: $218

FERNANDO SANCHEZ M. D.

Neurology

5,131

$496K

712
530 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$97
Average prescription price

Avg: $218

PRESTON HARRISON M.D.

Neurology

5,041

$1.1M

514
403 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$219
Average prescription price

Avg: $218

JUAN BAHAMON M.D.

Neurology

4,990

$1M

476
349 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 28%

$201
Average prescription price

Avg: $218

BORIS KAIM MD

Neurology

4,879

$1.35M

634
415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 28%

$276
Average prescription price

Avg: $218

ANN BASS M.D.

Neurology

4,775

$3.3M

396
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 28%

$691
Average prescription price

Avg: $218

KEVIN CONNER M.D.

Neurology

4,774

$1.7M

594
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$356
Average prescription price

Avg: $218

MARCO BENITEZ M.D

Neurology

4,726

$1.62M

479
338 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 5%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$343
Average prescription price

Avg: $218

BASEM HAMID MD

Neurology

4,636

$262K

482
289 are 65+

24%
patients receiving schedule two controlled substances

Avg: 2%

61%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$57
Average prescription price

Avg: $218

DONALD MILLIGAN

Neurology

4,506

$513K

233
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$114
Average prescription price

Avg: $218

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank